← Back to All Filings

Lantronix Director Awarded Routine RSU Grant

Low SignificanceNovember 6, 2025 at 7:02:06 PM EST

LANTRONIX INC

$LTRX4CIK: 0001114925

Subscribe to track LTRX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Lantronix Director Awarded Routine RSU Grant

Company: LANTRONIX INC (LTRX) Form: 4 | Filed: 2025-11-06 Significance: Low

Insider: Auker James Chris Title: null | Relationship: Director

Transaction: • Type: Grant • Shares: 17,081 (Restricted Stock Units) • Price: $0.00 • Value: $0 • Owned After: 10,387 common shares, 17,081 RSUs

Key Insight: A director received a routine RSU grant as part of their compensation. The filing also notes the vesting of a separate, prior grant of 10,387 shares.

Market Context: The new grant represents a potential future dilution of just 0.044% of shares outstanding for the $180M market cap company, which is considered immaterial.

Comprehensive Analysis

SEC Filing Analysis: LANTRONIX INC (LTRX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director at Lantronix received a routine grant of 17,081 Restricted Stock Units (RSUs) as part of their compensation package. A separate transaction in the same filing shows the vesting of 10,387 previously awarded RSUs into common stock.
  • Market Impact: Minimal. This is a standard compensation practice with a negligible dilution effect on existing shareholders.

Company Information

FieldValue
CompanyLANTRONIX INC
Ticker SymbolLTRX
CIK0001114925
IndustryComputer Communications Equipment

Insider Information

FieldValue
NameAuker James Chris
CIK0002076945
Title/Positionnull
RelationshipDirector

Transaction Details

This filing reports two primary events: a new grant and the vesting of a prior grant. The details below focus on the new grant.

FieldValue
Form Type4
Transaction Date2025-11-04
Transaction CodeA (Grant)
Security TypeRestricted Stock Units
Shares Involved17,081
Price Per Share$0.00
Total Value$0
Shares Owned After17,081 (of this RSU grant)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted17,081 (RSUs)
% of Shares Outstanding0.044%
Post-Transaction Ownership10,387 common shares (0.027% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a $180 million market cap, this equity grant is a standard and immaterial component of director compensation.
  • Ownership Concentration: Following the vesting of a separate award, the director's direct ownership in common stock is 10,387 shares, or just 0.027% of the company, which is not a significant stake.
  • Dilution Impact: The potential dilution from the new grant of 17,081 RSUs is approximately 0.044% of total shares outstanding, a negligible impact for existing shareholders.
  • Transaction Significance: The transaction is rated Low significance as it is a routine compensation grant representing a very small fraction of the company's equity.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Equity grants to directors are a common form of compensation and do not typically signal new information or a change in insider outlook.

Volume & Sentiment

  • Expected Volume Impact: None. The grant is an off-market transaction.
  • Sentiment Indicator: Neutral. This is a routine corporate governance event.

Additional Context

Transaction Notes

  • The filing covers two distinct events:
  1. A new grant of 17,081 RSUs on Nov 4, 2025, which vest over the following year.
  2. The vesting of 10,387 RSUs on Nov 5, 2025, from a previous grant, which converted into common stock.
Topics:#SECFiling#InsiderTrading#LTRX#Lantronix#Form4#StockGrant#RSU#Investing#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.